logo
OpenAI Releases GPT-5, Says It's Shutting Down All Previous Models

OpenAI Releases GPT-5, Says It's Shutting Down All Previous Models

Yahoo16 hours ago
OpenAI has released its long-awaited GPT-5 AI model, making it free to use for anybody as of today.
The Sam Altman-led company calls it "our smartest, fastest, and most useful model yet," making it "more useful responses across math, science, finance, law, and more."
"GPT-5 is the first time that it really feels like you're talking to an expert in any topic," Altman said during a press briefing today, likening it to Apple's iPhone switching to high-density Retina displays, whose individual pixels could no longer be made out by the naked eye.
Altman didn't hold back, asserting that it's the "best model in the world at coding" and "writing," as well as "health care, and a long list of things beyond that."
GPT-5 is a "reasoning" model, which means that it takes an iterative approach to problem solving before coming up with its final output.
The company is putting its money where its mouth is. "With GPT-5, we're deprecating all of our old models," said OpenAI researcher Tina Kim during the event, using a term the company uses when it's shutting down an obsolete model.
The company also claims that GPT-5 addresses some major pain points with the tech, including hallucinations, which continue to haunt pretty much all currently available AI models to this day, as well as cybersecurity.
But how all of this will shake out during real-world use remains to be seen. While OpenAI claims GPT-5 will make it easier than ever before to link one's Google account, Wired's recent reporting on glaring cybersecurity gaps plaguing ChatGPT should make any user think twice about using the company's Connectors feature.
The company also claims that GPT-5 is more robust to hijacking attempts — but we'll wait until hackers have had enough time with the tool to draw any conclusions.
OpenAI is aiming to enhance customizability by offering four preset personalities, including "cynic," "robot," "listener," and "nerd."
In spite of all the braggadocio, Altman admitted that OpenAI was still a very long way from fulfilling its core goal of achieving "artificial general intelligence" (AGI) — a poorly defined term that roughly denotes the point at which an AI's capabilities surpass those of a human — that would benefit all of humanity.
"I kind of hate the term AGI, because everyone at this point uses it to mean a slightly different thing, but [GPT-5] is a significant step forward towards models that are really capable," Altman said today. "We're still missing something quite important."
It also remains to be seen whether OpenAI has meaningfully addressed the issue of users suffering delusions in the form of "ChatGPT psychosis" with its latest model. Prior to today's announcement, the company released an update this week, announcing that it will be including lackluster "gentle reminders during long sessions to encourage breaks."
In short, GPT-5 appears to be yet another incremental step forward as the AI industry attempts to justify the tens of billions of dollars being poured into infrastructure buildouts to power incredibly environmentally damaging AI models.
The company already rushed out two "state-of-the-art open-weight language models," dubbed "gpt-oss-120b and gpt-oss-20b," earlier this week, though they're certain to now be overshadowed by GPT-5.
One thing's for sure: the former nonprofit is red hot right now. On Wednesday, news emerged that the company is deep into talks about a potential secondary stock sale that would value it at roughly half a trillion dollars.
More on OpenAI: It's Staggeringly Easy for Hackers to Trick ChatGPT Into Leaking Your Most Personal Data
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

World Liberty Financial token valued at $0.20 in Trump crypto project's ALT5 treasury deal
World Liberty Financial token valued at $0.20 in Trump crypto project's ALT5 treasury deal

Yahoo

time13 minutes ago

  • Yahoo

World Liberty Financial token valued at $0.20 in Trump crypto project's ALT5 treasury deal

World Liberty Financial's deal with ALT5 Sigma Corporation has put a value on WLFI, the Trump-backed DeFi project's token, for the first time since its sale last year. On Monday, ALT5 announced plans to pivot to become a so-called crypto treasury company, selling 200,000 new shares and using the proceeds to buy up the $1.5 billion worth of WLFI. The firm will swap half of the newly-issued shares directly for WLFI held by World Liberty Financial in a deal that values the token at $0.20, Matt Morgan, ALT5's chief investment officer, told DL News. It's not clear if World Liberty Financial is the only participant swapping WLFI tokens for shares. The firm said that several other unnamed institutional investors and venture capital firms participated in the share sale. It's the first time that WLFI has received a valuation since World Liberty Financial sold $550 million worth tokens to investors between October and March. At the time, investors paid varying prices for WLFI depending on how early in the sale they bought it. Large WLFI holders include Tron founder Justin Sun, who bought $75 million worth during the token sale. On its launch, WLFI was programmed so that buyers couldn't trade it, meaning that there was no way for the market to value the token. Conflict of interest The deal also highlights the growing crypto treasury company trend. Michael Saylor's Strategy was a trailblazer in this regard. The firm has issued debt or shares to buy Bitcoin since 2020, a ploy which has seen its shares skyrocket by over 3,500% since. Over the past year, a new wave of crypto treasury companies have copied Saylor's playbook on the back of a favourable crypto regulatory environment under the Trump administration. Many of these companies issue debt or shares to buy up their cryptocurrency of choice, and often emerge through reverse mergers with struggling publicly traded companies. Sometimes there's a conflict of interest between the treasury companies and the issuers of the crypto asset they buy. Tron Inc, a crypto treasury company that says it will buy up TRX, the native token of the Tron blockchain, has Weike Sun on its board, the father of Justin Sun. The firm listed the father-son relationship among its potential conflicts of interest in its S-3 filing last month. As a part of ALT5's crypto treasury swerve, the firm added several World Liberty Financial executives and backers to its board of directors. They include World Liberty Financial CEO Zach Witkoff, the project's COO Zak Folkman, and Eric Trump, President Donald Trump's son. All three new appointees hold WLFI and therefore have a financial interest in the token's value. Morgan said he's not at liberty to comment on matters that may involve commercially sensitive information relating to his role or ALT5 when asked about the potential conflict of interest of the board appointments. Trading the token The WLFI token is designed to govern World Liberty Financial. Those who hold the token can vote on changes to the protocol, its creators said. The project makes clear that it isn't a decentralised autonomous organisation, a type of crypto collective popular among DeFi projects. In July, WLFI holders voted to make the token tradable after the question was put to them by the project's creators. World Liberty Financial said in an X post that the token could begin trading as soon as the end of August. Tim Craig is DL News' Edinburgh-based DeFi Correspondent. Reach out with tips at tim@

Cardinal Health announces the addition of Solaris Health, the country's leading urology MSO, to The Specialty Alliance
Cardinal Health announces the addition of Solaris Health, the country's leading urology MSO, to The Specialty Alliance

Yahoo

time13 minutes ago

  • Yahoo

Cardinal Health announces the addition of Solaris Health, the country's leading urology MSO, to The Specialty Alliance

Adds over 750 providers to Cardinal Health's multi-specialty MSO platform, The Specialty Alliance Joins with recent urology acquisitions to bolster The Specialty Alliance's leadership in the urology therapeutic area Cardinal Health MSO platforms reach ~3,000 providers in 32 states upon transaction close DUBLIN, Ohio, Aug. 12, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that The Specialty Alliance, its multi-specialty management services organization (MSO) platform, has entered into a definitive agreement to acquire Solaris Health, the country's leading urology MSO, from Lee Equity Partners and Solaris Health physician owners. The transaction accelerates Cardinal Health's multi-specialty growth strategy by extending the reach of The Specialty Alliance, led by CEO James Weber, MD. Taken together with the recent acquisitions of Urology America and Potomac Urology and the just-completed acquisition of Academic Urology & Urogynecology, the acquisition of Solaris Health brings immediate scale to the Urology Alliance within The Specialty Alliance. Cardinal Health will provide approximately $1.9 billion in cash to The Specialty Alliance to enable the acquisition and will own approximately 75% of The Specialty Alliance after its acquisition of Solaris Health. Solaris Health physicians and several members of management will join GI Alliance physician owners and management as equity holders and operators in The Specialty Alliance. Solaris Health supports more than 750 providers across more than 250 practice locations in 14 states, with extensive reach into the local communities they serve. Solaris Health's resilient model and diverse revenue streams result from supporting a broad array of ancillary services, underpinned by a national MSO infrastructure. "Accelerating Specialty growth remains our top priority," said Jason Hollar, CEO, Cardinal Health. "As we previously highlighted, urology is an attractive specialty for us, and we are well-positioned to meet the comprehensive needs of community urologists through the robust combined capabilities of The Specialty Alliance, Specialty Networks and Cardinal Health." "The formation of our Urology Alliance within The Specialty Alliance marks a significant step in expanding our multi-specialty model to meet patient needs across more communities," said Dr. Weber. "As a physician, I know firsthand that integrated, coordinated care is critical to improving outcomes. By bringing Solaris Health's leading urology network into our platform, we're helping specialty providers focus more of their time and energy where it matters most, on their patients. Together, we're advancing a model that empowers physicians and prioritizes the highest standards of care." "Joining The Specialty Alliance's Urology Alliance strengthens our ability to deliver exceptional, patient-centered care through a physician-led, national platform," said Gary Kirsh, MD, CEO, Solaris Health. "This partnership expands our collaborative network of urology providers, allowing physicians to optimize care delivery and enhance patient access to specialized services in their local communities." Following the closing of the transaction, Dr. Kirsh will retire from his role leading Solaris Health and serve as a Senior Advisor to Cardinal Health. "Lee Equity would like to thank Dr. Kirsh for his visionary leadership and congratulate him on building the leading platform in urology," said Christian Chauvet, Partner, Lee Equity. "Dr. Kirsh has been a steadfast champion of independent medicine for his entire career, and we are proud to see Solaris Health and its exceptional physician base continue this legacy by joining the Urology Alliance." Cardinal Health expects the transaction to close by the end of calendar year 2025, subject to closing conditions, including the receipt of required physician and regulatory approvals. The transaction is expected to be slightly accretive to Cardinal Health's non-GAAP earnings per share (EPS) in the first 12 months following close. Cardinal Health expects to include the expected impact to its fiscal year 2026 guidance after the acquisition is completed. Capital Deployment In connection with the announcement of the acquisition, Cardinal Health reaffirmed its disciplined capital allocation framework. The company intends to finance the acquisition with a combination of cash on hand and new debt financing and plans to take a focused approach to paying down debt over the next 18 to 24 months. The company does not expect its deleveraging plans to change its previously outlined share repurchases and continues to expect to be within its targeted leverage range by the end of fiscal 2026. Advisors Goldman Sachs served as financial advisor to Cardinal Health on the acquisition of Solaris Health and Skadden, Arps, Slate, Meagher & Flom LLP and Katten Muchin Rosenman LLP served as legal advisors on the transaction. Centerview Partners served as financial advisor to Solaris Health and McDermott, Will & Emery served as legal advisor on the transaction. Goldman Sachs, BofA Securities and Wells Fargo serve as lead advisors on financing matters related to the acquisition. About Cardinal Health Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at and in our Newsroom. About Solaris Health Solaris Health is the leading U.S. healthcare management company in the urological field. Its affiliated medical practices have over 750 providers who annually care for over one million unique patients in 14 states. These practices and their providers are committed to enhancing access to specialty healthcare and continually improving patient outcomes. Empowering community providers allows them to make sure that every decision they make puts patient care at the forefront. Solaris Health is growing to meet the changing needs of healthcare providers, and to help them develop innovative ways to better deliver value and state-of-the-art care to their patients. Solaris Health is proud to be among the most innovative healthcare management companies in the United States. To learn more, visit About Lee Equity Partners, LLC Lee Equity Partners, LLC is a middle-market private equity firm that partners with businesses in the financial and healthcare services sectors. Over nearly two decades the firm has utilized its thematic based investment strategy and deep sector knowledge to identify and partner with talented management teams to accelerate growth and build market leading businesses. Additional information is available at Contacts Media: Erich Timmerman, and (614) 553-3853 Investors: Matt Sims, and (614) 553-3661 Cautions Concerning Forward-Looking Statements This news release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results or guidance, statements of outlook, and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include risks associated with our planned acquisition of Solaris Health, including the risk that we may not receive required regulatory approval or physician consents or otherwise fail to complete the transaction; the risk that we may fail to realize the anticipated strategic and financial benefits of the acquisition, whether as a result of external factors that may impact the profitability of the business or due to unforeseen challenges. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This news release reflects management's views as of August 12, 2025. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement. Forward-looking statements are aspirational and not guarantees or promises that goals, targets or projections will be met, and no assurance can be given that any commitment, expectation, initiative or plan in this news release can or will be achieved or completed. View original content to download multimedia: SOURCE Cardinal Health Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Elon Musk Reacts To Rivian, Lucid Accruing Cash Burn Of $88 Billion As Tesla Remains Only Free Cash Flow Generating Company: 'Harder Than It Looks'
Elon Musk Reacts To Rivian, Lucid Accruing Cash Burn Of $88 Billion As Tesla Remains Only Free Cash Flow Generating Company: 'Harder Than It Looks'

Yahoo

time13 minutes ago

  • Yahoo

Elon Musk Reacts To Rivian, Lucid Accruing Cash Burn Of $88 Billion As Tesla Remains Only Free Cash Flow Generating Company: 'Harder Than It Looks'

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Elon Musk says that achieving free cash flow with Tesla Inc. (NASDAQ:TSLA), when its company rivals like Lucid Group Inc. (NASDAQ:LCID), Rivian Technologies Inc. (NASDAQ:RIVN) are burning through cash, is difficult. 'Harder Than It Looks,' Says Elon Musk Taking to social media platform X on Sunday, Musk shared his thoughts when replying to a post illustrating a graph that showcased Tesla's positive free cash flow when compared with The same firms that backed Uber, Venmo and eBay are investing in this pre-IPO company disrupting a $1.8T market — "Ex Tesla, the shown companies accrued $88 billion in cash burn," the post said while also adding that Rivian was the most underperforming company in terms of cash burn."This is harder than it looks," Musk said in his response to the Sales Woes Worsen In Multiple Regions Despite the positive cash flow, the company's sales have been lackluster with double-digit declines in multiple regions across the globe, like France, as well as sales falling over 60% in countries like the UK. Tesla sales also fell in California by over 21% despite the company's Model 3 and Model Y topping the sales charts in the state, indicating falling sales domestically for Musk's EV giant. Tesla Secures Texas Ride-Hailing Permit However, Tesla securing a permit to operate ride-hailing services in Texas could provide the company with a major boost as Musk targets the ambitious goal of serving over half of the U.S. population with Tesla Robotaxis by the end of the year. Read Next: 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.30/share. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo Courtesy: This article Elon Musk Reacts To Rivian, Lucid Accruing Cash Burn Of $88 Billion As Tesla Remains Only Free Cash Flow Generating Company: 'Harder Than It Looks' originally appeared on Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store